Related Experiment Video

Updated: Aug 27, 2025

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
06:29

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Published on: July 30, 2020

3.2K

Aurora Kinases as Therapeutic Targets in Head and Neck Cancer

Theodore T Nguyen, Flaviane N Silva, Erica A Golemis

    Cancer Journal (Sudbury, Mass.)
    |September 27, 2022
    PubMed

    Insights

    Aurora kinases (AURKA and AURKB) are key regulators of cell division and cancer progression. Targeting these kinases offers a promising strategy for treating head and neck squamous cell carcinomas.

    Area of Science:

    • Oncology
    • Cell Biology
    • Molecular Biology

    Background:

    • Aurora kinases (AURKA and AURKB) are critical regulators of mitosis, involved in spindle formation, chromosome alignment, and condensation.
    • Beyond mitosis, Aurora kinases also regulate DNA replication and ciliary disassembly.
    • Their dysregulation in cancer, particularly head and neck squamous cell carcinomas (HNSCC), promotes aggressive phenotypes like enhanced oncogenic signaling and drug resistance.

    Purpose of the Study:

    • To investigate the role of Aurora kinases (AURKA and AURKB) as therapeutic targets in head and neck squamous cell carcinomas.
    • To explore the multifaceted functions of Aurora kinases in cell cycle regulation and cancer progression.
    • To highlight the therapeutic potential of Aurora kinase inhibitors in HNSCC treatment.

    Main Methods:

    • Review of existing literature on Aurora kinase functions and their implications in HNSCC.
    • Analysis of preclinical and clinical trial data for Aurora-targeted inhibitors.
    • Examination of molecular mechanisms by which Aurora kinases contribute to HNSCC aggressiveness.

    Main Results:

    • Elevated expression and activity of Aurora kinases are associated with aggressive HNSCC features.
    • Aurora kinases promote oncogenic signaling, stem cell identity, epithelial-mesenchymal transition, and drug resistance in HNSCC.
    • Numerous Aurora kinase inhibitors are under investigation, showing promise in preclinical and clinical settings.

    Conclusions:

    • Aurora kinases represent significant therapeutic targets for HNSCC due to their roles in promoting aggressive disease.
    • Targeted inhibition of AURKA and AURKB holds potential for improving treatment outcomes in head and neck squamous cell carcinomas.
    • Further research and clinical trials are warranted to fully elucidate the efficacy of Aurora kinase inhibitors in HNSCC.

    More Related Videos

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

    Published on: September 18, 2013

    18.2K
    Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma06:08

    Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

    Published on: June 2, 2023

    1.9K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    7.8K
    Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

    Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

    Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
    250
    Inhibition of Cdk Activity02:34

    Inhibition of Cdk Activity

    The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
    4.9K
    M-Cdk Drives Transition Into Mitosis02:15

    M-Cdk Drives Transition Into Mitosis

    Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
    Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
    M cyclin...
    5.7K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    3.9K
    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
    6.6K